Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses

v3.5.0.2
Accrued Expenses
 9 Months Ended
Sep. 30, 2016
Payables and Accruals [Abstract]  
Accrued Expenses

7. ACCRUED EXPENSES

 

Accrued expenses consisted of the following:

 

    September 30, 2016     December 31, 2015  
             
Accrued clinical operations and trials costs   $ 1,537,459     $ 365,188  
Accrued product development costs     664,930       152,018  
Accrued other     140,463       45,073  
Total   $ 2,342,852     $ 562,279